Please note, this OEL/ADE monograph also applies to Pheniramine maleate (CAS RN 132-20-7), Pheniramine aminosalicylate (CAS RN 2508-73-8) and Pheniramine hydrochloride (CAS RN 25332-09-6). .Pheniramine maleate is used to treat multiple symptoms including hay fever, allergic dermatitis, and itching and to prevent and treat inner ear disorders. Pheniramine is a histamine H1 antagonist with little sedative action. Binding to H1 receptors inhibits phospholipase A2 and production of nitric oxide which relaxes smooth muscles. It also decreases vascular permeability and allergic reactions.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Pheniramine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.